Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL3142769

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
CCc1c[nH]c(=O)n([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@]3(OS(=O)(=O)C=C3N)[C@H]2O[Si](C)(C)C(C)(C)C)c1=O

Basic Information

ChEMBL ID CHEMBL3142769
Phase Preclinical
Structure Type MOL
InChI Key JFKOEBHLWIQYBL-XDSPWSPCSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names

Molecular Properties

603.9
MW (Da)

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C25H45N3O8SSi2
MW 603.89

Activity Summary

EC50 1 meas. best 7.18

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
MT4
CHEMBL388
EC50 7.18 7.18 66.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
MT4 EC50 = 66.0 nM 7.18 Concentration required to inhibit HIV-1 induced cytopathicity in MT-4 cells by 5... 1501224

Literature References

PubMed DOI Target Context # Activities
1501224 10.1021/jm00094a009 MT4 2
1501224 10.1021/jm00094a009 Unchecked 1

Data from ChEMBL 36 via Core Engine